149 related articles for article (PubMed ID: 19603101)
1. Role of E2F1-cyclin E1-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs.
Dapas B; Farra R; Grassi M; Giansante C; Fiotti N; Uxa L; Rainaldi G; Mercatanti A; Colombatti A; Spessotto P; Lacovich V; Guarnieri G; Grassi G
Mol Med; 2009; 15(9-10):297-306. PubMed ID: 19603101
[TBL] [Abstract][Full Text] [Related]
2. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
[TBL] [Abstract][Full Text] [Related]
3. Hammerhead ribozymes targeted against cyclin E and E2F1 cooperate to down-regulate coronary smooth muscle cell proliferation.
Grassi G; Schneider A; Engel S; Racchi G; Kandolf R; Kuhn A
J Gene Med; 2005 Sep; 7(9):1223-34. PubMed ID: 15772936
[TBL] [Abstract][Full Text] [Related]
4. PKCdelta mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle.
Bowles DK; Maddali KK; Dhulipala VC; Korzick DH
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C805-13. PubMed ID: 17507429
[TBL] [Abstract][Full Text] [Related]
5. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
6. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
7. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
[TBL] [Abstract][Full Text] [Related]
8. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
9. Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cells.
Chen R; Chen Y; Yuan Y; Zou X; Sun Q; Lin H; Chen X; Liu M; Deng Z; Yao Y; Guo D; Zhang Y
Thorac Cancer; 2020 Jun; 11(6):1594-1602. PubMed ID: 32338437
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.
Choiniere J; Wu J; Wang L
Mol Pharmacol; 2017 Mar; 91(3):189-196. PubMed ID: 28003426
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose.
Zanetti M; Stocca A; Dapas B; Farra R; Uxa L; Bosutti A; Barazzoni R; Bossi F; Giansante C; Tedesco F; Cattin L; Guarnieri G; Grassi G
J Mol Med (Berl); 2008 Feb; 86(2):185-95. PubMed ID: 17876565
[TBL] [Abstract][Full Text] [Related]
12. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
13. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-874-mediated inhibition of the major G
Ghosh T; Varshney A; Kumar P; Kaur M; Kumar V; Shekhar R; Devi R; Priyanka P; Khan MM; Saxena S
J Biol Chem; 2017 Dec; 292(52):21264-21281. PubMed ID: 29109143
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.
Caldon CE; Sergio CM; Burgess A; Deans AJ; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):606-17. PubMed ID: 23324395
[TBL] [Abstract][Full Text] [Related]
16. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
17.
Kikuchi K; Kaida D
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769053
[TBL] [Abstract][Full Text] [Related]
18. The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner.
Por E; Byun HJ; Lee EJ; Lim JH; Jung SY; Park I; Kim YM; Jeoung DI; Lee H
J Biol Chem; 2010 May; 285(19):14475-85. PubMed ID: 20220142
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
